Tenet Healthcare Corporation $THC Position Increased by M&T Bank Corp

Key Points

• M&T Bank Corp increased its stake in Tenet Healthcare by 1,944.8% in Q4, ending the period with 104,304 shares worth about $20.7 million, and institutional investors now own roughly 95.44% of the company.
• Tenet beat quarterly expectations with $4.70 EPS (vs. $4.08 est.) and $5.53B revenue (vs. $5.47B est.), and set FY2026 guidance of 16.19–18.47 EPS (analysts forecast ~17.31 EPS).
• Research firms have grown more bullish—multiple analysts reiterated or raised "overweight"/"outperform" ratings, and the stock carries a consensus rating of Moderate Buy with a price target of $250.56.

M&T Bank Corp grew its stake in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 1,944.8% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 104,304 shares of the company's stock after acquiring an additional 99,203 shares during the period. M&T Bank Corp owned about 0.12% of Tenet Healthcare worth $20,727,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of THC. NewEdge Advisors LLC lifted its stake in Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company's stock valued at $389,000 after buying an additional 166 shares in the last quarter. Jones Financial Companies Lllp raised its stake in Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company's stock valued at $229,000 after purchasing an additional 1,274 shares during the period. Sivia Capital Partners LLC acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at about $290,000. Quantbot Technologies LP acquired a new position in shares of Tenet Healthcare in the second quarter worth $65,000. Finally, Amundi boosted its position in Tenet Healthcare by 4,207.8% during the second quarter. Amundi now owns 27,010 shares of the company's stock valued at $4,652,000 after purchasing an additional 26,383 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on THC shares. Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. Leerink Partners boosted their price target on Tenet Healthcare from $255.00 to $264.00 and gave the company an "outperform" rating in a research note on Friday, February 20th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $265.00 price objective on shares of Tenet Healthcare in a research report on Monday, February 16th. Barclays lifted their target price on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an "overweight" rating in a research note on Friday, February 13th. Finally, Morgan Stanley restated an "overweight" rating and set a $260.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $250.56.

Insiders Place Their Bets

In related news, EVP Paola M. Arbour sold 6,500 shares of the company's stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the transaction, the executive vice president directly owned 29,291 shares in the company, valued at $6,983,853.13. This represents a 18.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider R. Scott Ramsey sold 8,017 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 46,517 shares of company stock valued at $10,943,111 in the last three months. Company insiders own 0.81% of the company's stock.

Tenet Healthcare Stock Down 1.6%

THC opened at $188.19 on Friday. Tenet Healthcare Corporation has a twelve month low of $120.74 and a twelve month high of $247.21. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The business has a 50 day moving average price of $212.43 and a 200 day moving average price of $204.79. The firm has a market cap of $16.49 billion, a P/E ratio of 12.15, a price-to-earnings-growth ratio of 0.92 and a beta of 1.49.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating analysts' consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company's quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter last year, the firm posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Research analysts forecast that Tenet Healthcare Corporation will post 17.31 EPS for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.